Process Development and cGMP Manufacturing of a Recombinant Ricin Vaccine: an Effective and Stable Recombinant Ricin A-Chain Vaccine—RVE<i>c</i>TM
نویسندگان
چکیده
Ricin is a potent toxin and a potential bioterrorism weapon with no specific countermeasures or vaccines available. The holotoxin is composed of two polypeptide chains linked by a single disulfide bond: the A-chain (RTA), which is an N-glycosidase enzyme, and the B-chain (RTB), a lectin polypeptide that binds galactosyl moieties on the surface of the mammalian target cells. Previously (McHugh et al.), a recombinant truncated form of RTA (rRTA1-33/ 44-198 protein, herein denoted RVEa TM) expressed in Escherichia coli using a codon-optimized gene was shown to be non-toxic, stable, and protective against a ricin challenge in mice. Here, we describe the process development and scale-up at the 12 L fermentation scale, and the current Good Manufacturing Practice (cGMP)-compliant production of RVEc TM at the 40 L scale. The average yield of the final purified bulk RVEc TM is approximately 16 g/kg of wet cell weight or 1.2 g/L of fermentation broth. The RVEc TM was [99% pure by three HPLC methods and SDS-PAGE. The intact mass and peptide mapping analysis of RVEc TM confirmed the identity of the product and is consistent with the absence of posttranslational modifications. Potency assays demonstrated that RVEc TM was immuno-protective against lethal ricin challenge and elicited neutralizing anti-ricin antibodies in 95–100% of the vaccinated mice. Introduction The ricin toxin is a 64 kilodalton (kDa) protein produced by the seeds of the castor oil plant (Ricinus communis). The mechanism of action of this opportunistic ribotoxin has been thoroughly studied. 1,2 The holotoxin is a glycosylated hetero-dimeric protein that is composed of two chains, A and B, joined by a single disulfide bond. 3–5 The A-chain (RTA) is an enzyme that inactivates the 28S ribosomal ribonucleic acid (rRNA) by hydrolytic cleavage of the N-glycosidic bond of the essential adenine nucleotide (A4324) of the ribo-some. 6,7 The depurination site in the rRNA is part of a conserved sequence present in nearly all eukaryotic cells and it is known as the sarcin-ricin loop. 8 The B-chain (RTB) is a lectin that binds to galactose moieties presented by cell-surface glycopeptides or glycolipids, inducing endocytosis of the holotoxin. The combination of the internalization by the toxin and the cytosolic activity of the A-chain (kcat/Km $10 7 M À1 s À1) 6 allows a single ricin molecule to kill a eu-karyotic cell by damaging protein synthesis. 9 The holotoxin is taken up by cells through endocytosis, incorporated into vesicles, and transported …
منابع مشابه
Process development and cGMP manufacturing of a recombinant ricin vaccine: an effective and stable recombinant ricin A-chain vaccine-RVEc™.
Ricin is a potent toxin and a potential bioterrorism weapon with no specific countermeasures or vaccines available. The holotoxin is composed of two polypeptide chains linked by a single disulfide bond: the A-chain (RTA), which is an N-glycosidase enzyme, and the B-chain (RTB), a lectin polypeptide that binds galactosyl moieties on the surface of the mammalian target cells. Previously (McHugh e...
متن کاملExtraction, Cloning and Expression of RTB, as a Vaccine Adjuvant/Carrier,in E. coli and Production of Mouse Polyclonal Antibody (Anti-B chain Abs)
Ricin, the toxic lectin extracted from the castor bean plant (Ricinus communis), consists of an A chain (RTA) and a B chain (RTB). Anti-A chain Abs and anti-B chain Abs can neutralize toxins in vivo and in vitro via blocking the binding of the toxin to the cell. Also, RTB protein is able to serve as an antigen deliver to the mucosal immune system and act as an immunoad...
متن کاملImproved Formulation of a Recombinant Ricin A-Chain Vaccine Iincreases its Stability and Effective Antigenicity
Ricin is a potent toxin associated with bioterrorism for which no vaccine or specific countermeasures are currently available. A stable, non-toxic and immunogenic recombinant ricin A-chain vaccine (RTA 1-33/44-198) has been developed by protein engineering. We identified optimal formulation conditions for this vaccine under which it remained stable and potent in storage for up to 18 months, and...
متن کاملImproved formulation of a recombinant ricin A-chain vaccine increases its stability and effective antigenicity.
Ricin is a potent toxin associated with bioterrorism for which no vaccine or specific countermeasures are currently available. A stable, non-toxic and immunogenic recombinant ricin A-chain vaccine (RTA 1-33/44-198) has been developed by protein engineering. We identified optimal formulation conditions for this vaccine under which it remained stable and potent in storage for up to 18 months, and...
متن کاملImmunogenicity of a New Recombinant IpaC from Shigella dysenteriae Type I in Guinea Pig as a Vaccine Candidate
Background: Recombinant vaccine technology is one of the most developed means in controlling infectious diseases. However, an effective vaccine against Shigella is still missing. Objective: To evaluate recombinant IpaC protein of Shigella as a vaccine candidate. Methods: In this study we cloned IpaC gene into an expression vector in prokaryotic system. The protein expression was evaluated by SD...
متن کامل